SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-003345
Filing Date
2021-01-12
Accepted
2021-01-12 21:43:01
Documents
1
Period of Report
2021-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9669
  Complete submission text file 0001209191-21-003345.txt   11086
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404
Business Address
Sauer Paul (Reporting) CIK: 0001813796 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 21524948